Product Introduction

The fluorecare® SAA Test Kit (Serum Amyloid A) developed by Microprofit is a quantitative immunofluorescence assay (FIA) designed for the accurate detection of serum amyloid A levels in human serum and plasma. As part of the fluorecare® POCT diagnostic platform, this test kit enables rapid and reliable quantitative analysis, supporting efficient clinical decision-making in laboratories, hospitals, and point-of-care testing environments.

Detection Principle

The fluorecare® SAA test kit utilizes fluorescence immunochromatographic assay technology based on a double-antibody sandwich method. SAA in the sample binds with fluorescent-labeled antibodies to form antigen-antibody complexes, which are captured on the test line. The fluorescence signal is positively correlated with the SAA concentration and is detected and analyzed by the fluorecare® immunofluorescence analyzer, enabling accurate and quantitative measurement.

Clinical Applications

• Early indication of viral and bacterial infections

• Differentiation between viral and bacterial infection when combined with CRP

• Monitoring of acute-phase inflammatory response

• Assessment of infection severity and treatment response

• Clinical laboratory and decentralized POCT testing

Frequently Asked Questions

Q: What is the fluorecare® SAA test kit used for?

A: The fluorecare® SAA test kit is used for quantitative detection of serum amyloid A, a sensitive acute-phase marker that helps identify infection and inflammation, especially in early viral infections.

Q: How fast is the fluorecare® SAA test?

A: The test provides accurate results within about 8 minutes using the fluorecare® immunofluorescence analyzer.

Q: What samples can be used for this test?

A: Serum and plasma samples are suitable for testing with the fluorecare® SAA test kit.

Q: Is the fluorecare® SAA test suitable for POCT use?

A: Yes, it is specifically designed for point-of-care testing environments.

Compatible Analyzer

The fluorecare® SAA test kit is specifically designed to work with the fluorecare® immunofluorescence analyzer, providing fast, accurate, and quantitative results. This integrated POCT solution ensures efficient workflow and reliable performance for laboratories, clinics, and decentralized healthcare settings.

• Quantitative detection based on immunofluorescence assay (FIA)

• Rapid results within about 8 minutes

• High sensitivity and specificity

• Seamless integration with fluorecare® POCT platform

• Stable performance with internal calibration

• User-friendly operation with minimal training required

• Suitable for laboratory and point-of-care testing scenarios